Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response.
Kuperberg M, Köhler-Forsberg O, Shannon AP, George N, Greenebaum S, Bowden CL, Calabrese JR, Thase M, Shelton RC, McInnis M, Deckersbach T, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Iosifescu DV, Ostacher MJ, Sylvia LG, McElroy SL, Nierenberg AA. Kuperberg M, et al. Among authors: kocsis jh. J Affect Disord. 2022 Mar 1;300:41-49. doi: 10.1016/j.jad.2021.12.047. Epub 2021 Dec 21. J Affect Disord. 2022. PMID: 34952123 Clinical Trial.
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression.
Thase ME, Rush AJ, Howland RH, Kornstein SG, Kocsis JH, Gelenberg AJ, Schatzberg AF, Koran LM, Keller MB, Russell JM, Hirschfeld RM, LaVange LM, Klein DN, Fawcett J, Harrison W. Thase ME, et al. Among authors: kocsis jh. Arch Gen Psychiatry. 2002 Mar;59(3):233-9. doi: 10.1001/archpsyc.59.3.233. Arch Gen Psychiatry. 2002. PMID: 11879161 Clinical Trial.
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.
Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. Rush AJ, et al. Among authors: kocsis jh. Biol Psychiatry. 2003 Sep 1;54(5):573-83. doi: 10.1016/s0006-3223(02)01866-8. Biol Psychiatry. 2003. PMID: 12946886 Clinical Trial.
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
Schatzberg AF, Rush AJ, Arnow BA, Banks PL, Blalock JA, Borian FE, Howland R, Klein DN, Kocsis JH, Kornstein SG, Manber R, Markowitz JC, Miller I, Ninan PT, Rothbaum BO, Thase ME, Trivedi MH, Keller MB. Schatzberg AF, et al. Among authors: kocsis jh. Arch Gen Psychiatry. 2005 May;62(5):513-20. doi: 10.1001/archpsyc.62.5.513. Arch Gen Psychiatry. 2005. PMID: 15867104 Clinical Trial.
The state of knowledge of chronic depression.
Gelenberg AJ, Kocsis JH, McCullough JP Jr, Ninan PT, Thase ME. Gelenberg AJ, et al. Among authors: kocsis jh. J Clin Psychiatry. 2006 Feb;67(2):179-84. doi: 10.4088/jcp.v67n0202. J Clin Psychiatry. 2006. PMID: 16566611 Free article. No abstract available.
Dropouts versus completers among chronically depressed outpatients.
Arnow BA, Blasey C, Manber R, Constantino MJ, Markowitz JC, Klein DN, Thase ME, Kocsis JH, Rush AJ. Arnow BA, et al. Among authors: kocsis jh. J Affect Disord. 2007 Jan;97(1-3):197-202. doi: 10.1016/j.jad.2006.06.017. Epub 2006 Jul 20. J Affect Disord. 2007. PMID: 16857266 Clinical Trial.
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.
Kocsis JH, Thase ME, Trivedi MH, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT, Keller MB. Kocsis JH, et al. J Clin Psychiatry. 2007 Jul;68(7):1014-23. doi: 10.4088/jcp.v68n0706. J Clin Psychiatry. 2007. PMID: 17685736 Clinical Trial.
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Dunlop BW, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen R, Yan B, Ahmed S, Schmidt M, Ninan PT. Keller MB, et al. Among authors: kocsis jh. Biol Psychiatry. 2007 Dec 15;62(12):1371-9. doi: 10.1016/j.biopsych.2007.04.040. Epub 2007 Sep 7. Biol Psychiatry. 2007. PMID: 17825800 Clinical Trial.
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT. Keller MB, et al. Among authors: kocsis jh. J Clin Psychiatry. 2007 Aug;68(8):1246-56. doi: 10.4088/jcp.v68n0812. J Clin Psychiatry. 2007. PMID: 17854250 Clinical Trial.
184 results